Skip to main content
Cronos Group Inc. (CRON)
NASDAQ: CRON · IEX Real-Time Price · USD
2.590
+0.090 (3.60%)
At close: May 31, 2024, 4:00 PM
2.600
+0.010 (0.39%)
After-hours: May 31, 2024, 7:48 PM EDT

Cronos Group Revenue

Cronos Group had revenue of $93.03M in the twelve months ending March 31, 2024, with 11.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $25.29M with 29.72% year-over-year growth. In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth.

Revenue (ttm)
$93.03M
Revenue Growth
+11.37%
P/S Ratio
10.63
Revenue / Employee
$261,331
Employees
356
Market Cap
989.41M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202387.24M492.00K0.57%
Dec 31, 202286.75M22.19M34.37%
Dec 31, 202164.56M17.84M38.19%
Dec 31, 202046.72M22.97M96.71%
Dec 31, 201923.75M11.63M95.94%
Dec 31, 201812.12M8.97M285.16%
Dec 31, 20173.15M2.72M638.69%
Dec 31, 2016426.03K--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ironwood Pharmaceuticals 413.55M
Artivion 368.21M
MiMedx Group 334.51M
Innoviva 311.59M
Gyre Therapeutics 140.62M
BioLife Solutions 137.30M
Arcturus Therapeutics Holdings 124.53M
Silence Therapeutics 33.86M
Revenue Rankings

CRON News

More News